Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
Format:	Journal article
Sprog:	English
Udgivet:	Springer Nature 2020

Lignende værker

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
af: Yasunori Watanabe, et al.
Udgivet: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
af: Watanabe, Y, et al.
Udgivet: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
af: Crispin, M, et al.
Udgivet: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
af: Crispin, M, et al.
Udgivet: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
af: Seabright, GE
Udgivet: (2019)

Beyond Shielding: The Roles of Glycans in the SARS-CoV‑2 Spike Protein
af: Lorenzo Casalino, et al.
Udgivet: (2020-09-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
af: Pritchard, L, et al.
Udgivet: (2015)

Architecture of the HIV-1 glycan shield
af: Pritchard, L
Udgivet: (2014)

Mapping the glycan shields of enveloped viruses
af: Watanabe, Y
Udgivet: (2020)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
af: Behrens, AJ, et al.
Udgivet: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
af: Joel D. Allen, et al.
Udgivet: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
af: Bonomelli, C, et al.
Udgivet: (2011)

Glycosylator: a Python framework for the rapid modeling of glycans
af: Thomas Lemmin, et al.
Udgivet: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
af: Amr Sobhi Gouda, et al.
Udgivet: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
af: Le, N, et al.
Udgivet: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
af: Camille Bonomelli, et al.
Udgivet: (2011-01-01)

Fine structure of the HIV-1 glycan shield
af: Behrens, A
Udgivet: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
af: Weiwei Peng, et al.
Udgivet: (2022-08-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
af: Mingjun Yang, et al.
Udgivet: (2017-06-01)

Glycan Nanostructures of Human Coronaviruses
af: Guo W, et al.
Udgivet: (2021-07-01)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
af: Sommerstein, R, et al.
Udgivet: (2015)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
af: Rami Sommerstein, et al.
Udgivet: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
af: Rising, T, et al.
Udgivet: (2006)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
af: Parham Jabbarzadeh Kaboli, et al.
Udgivet: (2025-02-01)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
af: Mihaela-Olivia Dobrica, et al.
Udgivet: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
af: Marie-Estelle Losfeld, et al.
Udgivet: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
af: Julien J, et al.
Udgivet: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
af: Qing Wei, et al.
Udgivet: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
af: Bénédicte Machiels, et al.
Udgivet: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
af: Esteban Cruz, et al.
Udgivet: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
af: Naveen Vankadari, et al.
Udgivet: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
af: Pejchal, R, et al.
Udgivet: (2011)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
af: Jonathan J Lyons, et al.
Udgivet: (2015-06-01)

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
af: Ruofan Li, et al.
Udgivet: (2024-10-01)

Fine structure of the HIV-1 glycan shield - Supplementary information
af: Behrens, A
Udgivet: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
af: Tongqing Zhou, et al.
Udgivet: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
af: Muriel Lavie, et al.
Udgivet: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
af: Pritchard, L, et al.
Udgivet: (2015)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
af: Rajesh P Ringe, et al.
Udgivet: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
af: Davis, B, et al.
Udgivet: (2000)